Search Results 1-10 of 17165 for diabetes stem cell treatment
Combining gene therapy with stem cell therapy. Photograph of insulin-producing human islet cells (red) regenerated through the induced pluripotent.
About this study. The purpose of this study is to assess the safety and tolerability of intra-arterially delivered mesenchymal stem/stromal cells (MSC) to a ...
Stem cells are being studied to treat type 1 diabetes, Parkinson's disease, amyotrophic lateral sclerosis, heart failure, osteoarthritis and other conditions.
Regenerative, cell-based therapy applying MSCs holds promise to delay the progression of kidney disease in individuals with diabetes mellitus. Our clinical ...
Peterson, principal investigator. Alpha cells in the pancreas produce glucagon, which is released to correct low blood sugar levels. However, in diabetes these ...
Peterson's lab can mass-produce islet cells from these induced pluripotent stem cells and transplant them in preclinical models to test their potential to cure ...
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease Rochester, MN. The purpose of this study is to assess the safety and tolerability of intra ...
... diabetes and breakdowns in stem cells in older ... Treatment with Janus ... treating age-related stem cell and tissue dysfunction and metabolic disease.
Hence, there is urgent need for novel therapies to slow the progression of DKD and optimize the health of this patient population. The purpose of this study is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.